SEC Form D · filed January 19, 2022
AmbAgon Therapeutics Inc
Location
San Francisco, CA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (36)
Peter Dudek · San Francisco, CADirectorChristian Ottmann · San Francisco, CAExecRoel Bulthuis · San Francisco, CADirectorJanwillem Naesens · San Francisco, CADirectorNancy Pryer · San Francisco, CAExecMelissa Mccracken · San Francisco, CADirectorScott Clarke · San Francisco, CAExec · DirectorMichelle Arkin · San Francisco, CADirectorAdam Rosenberg · San Francisco, CADirectorMargarita Chavez · San Francisco, CADirectorJosh Seidenfeld · San Francisco, CAExecBryan Miller · San Francisco, CAExecHarold Hope · New York, NYExecMichael O. Reinardy · Petaluma, CADirectorBahram Nour-Omid · Los Angeles, CADirectorRaanan Agus · New York, NYDirectorAlia Natafgi · Westlake, OHExecJason B. Campbell · Cape May Court House, NJExecTarek Kteleh · Westlake, OHExec · DirectorChristopher J. Strahl · Portland, ORExecRyan Whitney · Dayton, OHDirectorHazem Nouraldin · Westlake, OHDirectorRonald E. Silva · Petaluma, CADirectorAnthony J. Varone · Powell, OHDirectorBlake Hylands · Toronto, Ontario, CanadaDirectorMaziyar Yousefizad · St. Petersburg, FLDirectorGeorge Xanthakys · Grand Duchy of Luxembourg, LuxembourgDirectorHyana Kim · Grand Duchy of Luxembourg, LuxembourgDirectorMichael Bell · DENVER, CODirectorCraig Weiss · Memphis, TNDirectorChris Corica · Amherst, NYExecRichard M. Ferrari · LOS GATOS, CAExecStephen H. Hochschuler · LOS GATOS, CAExec · DirectorFrank M. Fischer · LOS GATOS, CADirectorRobert K. Weigle · LOS GATOS, CAExecSteven M. Foster · LOS GATOS, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗